Suppr超能文献

服用加巴喷丁依那卡比后,不同脂肪含量食物对加巴喷丁临床药代动力学的影响。

The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil.

作者信息

Lal R, Sukbuntherng J, Luo W, Huff F J, Zou J, Cundy K C

机构信息

XenoPort, Inc., Santa Clara, CA 95051, USA.

出版信息

Int J Clin Pharmacol Ther. 2010 Feb;48(2):120-8. doi: 10.5414/cpp48120.

Abstract

UNLABELLED

Gabapentin enacarbil, an actively transported prodrug of gabapentin, provides sustained and dose-proportional exposure to gabapentin.

OBJECTIVE

To evaluate the effect of food of varying fat content on the pharmacokinetics and tolerability of gabapentin enacarbil. METHODS, MATERIALS AND SUBJECTS: A randomized, open-label, crossover study of 1,200 mg gabapentin enacarbil was conducted in 12 healthy adults, under four conditions: fasted, or following low-fat (200 - 300 kcal total, approximately 6% from fat), moderate-fat (500 - 600 kcal total, approximately 30% from fat) or high-fat meals (1,000 kcal total, approximately 50% from fat), separated by a washout period of >or= 5 days.

RESULTS

Ten subjects completed treatment under all four conditions. Data from all subjects were used for pharmacokinetic and safety analyses unless stated otherwise. Mean (standard deviation) bioavailability (based on urinary recovery) of gabapentin from gabapentin enacarbil was 42.0 (6.1)% (fasted), 64.3 (13.2)% (low-fat meal), 64.9 (16.9)% (moderate-fat meal), and 76.1 (14.4)% (high-fat meal). Gabapentin exposures (AUC(inf)) in fed conditions were 23% (low-fat meal), 31% (moderate-fat meal), and 40% (high-fat meal) greater than the exposure under fasted condition. Fed conditions did not significantly delay median t(max), but a trend for delayed gabapentin enacarbil absorption was seen in t(max) ranges following moderate- and high-fat meals compared with the fasted state or low-fat meal. The most commonly reported treatment-emergent adverse events (TEAEs) were dizziness (4 subjects), balance disorder (4 subjects) and somnolence (3 subjects). All TEAEs were rated as mild in intensity.

CONCLUSION

Administration of gabapentin enacarbil with food enhanced gabapentin exposure compared with fasted conditions, regardless of the fat or caloric content, and gabapentin enacarbil was generally well tolerated.

摘要

未标记

加巴喷丁依那卡比是加巴喷丁的一种主动转运前体药物,能使加巴喷丁实现持续且剂量成正比的暴露。

目的

评估不同脂肪含量的食物对加巴喷丁依那卡比药代动力学和耐受性的影响。方法、材料与受试者:对12名健康成年人进行了一项随机、开放标签、交叉研究,给予1200毫克加巴喷丁依那卡比,分四种情况:空腹,或在低脂(总热量200 - 300千卡,约6%来自脂肪)、中度脂肪(总热量500 - 600千卡,约30%来自脂肪)或高脂肪餐(总热量1000千卡,约50%来自脂肪)后服用,各情况之间间隔洗脱期≥5天。

结果

10名受试者在所有四种情况下均完成治疗。除非另有说明,所有受试者的数据均用于药代动力学和安全性分析。加巴喷丁依那卡比中加巴喷丁的平均(标准差)生物利用度(基于尿液回收率)在空腹时为42.0(6.1)%,低脂餐后为64.3(13.2)%,中度脂肪餐后为64.9(16.9)%,高脂肪餐后为76.1(14.4)%。进食条件下加巴喷丁的暴露量(AUC(inf))比空腹条件下高23%(低脂餐)、31%(中度脂肪餐)和40%(高脂肪餐)。进食条件并未显著延迟中位t(max),但与空腹状态或低脂餐相比,在中度和高脂肪餐后的t(max)范围内观察到加巴喷丁依那卡比吸收有延迟趋势。最常报告的治疗中出现的不良事件(TEAE)为头晕(4名受试者)、平衡障碍(4名受试者)和嗜睡(3名受试者)。所有TEAE强度均为轻度。

结论

与空腹条件相比,加巴喷丁依那卡比与食物一起服用可增加加巴喷丁的暴露量,无论脂肪或热量含量如何,且加巴喷丁依那卡比总体耐受性良好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验